Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-03-02 @ 8:19 AM
Study NCT ID:
NCT00940758
Status:
COMPLETED
Last Update Posted:
2017-04-06
First Post:
2009-07-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy
Sponsor:
PharmaEngine
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PIST-CRC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None